3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Anemia
1
Interventions
pembrolizumab
18
Specimen Handling
16
Magnetic Resonance Spectroscopy
11
Biopsy
11
Paclitaxel
8
Carboplatin
8
trastuzumab deruxtecan
6
Pemetrexed
6
Nivolumab
6
Irinotecan
6
Fulvestrant
6
Bevacizumab
6
Radiosurgery
5
Leucovorin
5
Gemcitabine
5
Fluorouracil
5
Cetuximab
5
palbociclib
4
Oxaliplatin
4
Letrozole
4
Cisplatin
4
olaparib
3
durvalumab
3
Taxes
3
Ipilimumab
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
ibrutinib
×
30 days
×
Clear all
No trials found.